DV
Dividend Vision

LFCR — Lifecore Biomedical Inc.

Lifecore Biomedical Inc. (LFCR)

Total return is -63.0% over the past 30.5 years, 1979.2 points behind SPY at 1916.2%. Its deepest 1-year drawdown was 58.5%.

Lifecore Biomedical is an integrated contract development and manufacturing organization that provides services including development, manufacture, and aseptic fill-and-finish of sterile injectable pharmaceutical and medical device products, as well as manufacturing pharmaceutical-grade hyaluronic acid for ophthalmic and orthopedic applications. The company does not currently distribute dividends. Lifecore Biomedical appeals to investors seeking exposure to the specialized pharmaceutical manufacturing and development sector rather than those focused on dividend income.

LFCR key facts

Asset type
Stock
Asset class
Equity
Inception date
02/15/1996
Last close
$4.72
Market cap
$174,043,648
Average volume
142200.0
Beta
1.062
Payout ratio
0.0
Forward P/E
8.673
EPS
$-1.27